{"disease":{"id":"dyskinesias","name":"dyskinesias"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05317390","title":"Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false},{"nct_id":"NCT06585605","title":"A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT04453995","title":"A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07023224","title":"Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Izmir Bakircay University","has_results":false},{"nct_id":"NCT04086160","title":"Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Dr WANG Shumei","has_results":false},{"nct_id":"NCT03956979","title":"A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Contera Pharma","has_results":false},{"nct_id":"NCT02153645","title":"Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":87,"lead_sponsor_name":"Adamas Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT01474421","title":"Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04553835","title":"Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Dr WANG Shumei","has_results":false},{"nct_id":"NCT03270189","title":"Effect of the Visual Information Change in Functional Dystonia","phase":"NA","overall_status":"TERMINATED","enrollment_count":48,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT05044572","title":"Comparison of Open Chain Kinetic Exercises and Forward Head Posture Correction in Type II Scapular Dyskinesia","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT04377945","title":"Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Bukwang Pharmaceutical","has_results":false},{"nct_id":"NCT00086294","title":"ACP-103 to Treat Parkinson's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT04912115","title":"Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":30,"lead_sponsor_name":"PharmaTher Inc.","has_results":false},{"nct_id":"NCT04857359","title":"Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Addex Pharma S.A.","has_results":false},{"nct_id":"NCT06618157","title":"Connectomic Guided DBS for Parkinson's Disease","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":20,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03034538","title":"An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease","phase":"PHASE4","overall_status":"SUSPENDED","enrollment_count":20,"lead_sponsor_name":"The Cooper Health System","has_results":false},{"nct_id":"NCT05116813","title":"Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Addex Pharma S.A.","has_results":false},{"nct_id":"NCT04929795","title":"Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Dr WANG Shumei","has_results":false},{"nct_id":"NCT04351360","title":"Pilot Study on Caffeine Efficiency in ADCY5-related Dyskinesia","phase":"","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT05516875","title":"Open-Label Extension Study of ASTORIA","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Contera Pharma A/S","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}